NCT03955146Phase 3Terminated

Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Study sponsor: Kyntra Bio

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-03-20Actual
Enrollment · participants393Actual
Source updated2024-09-19Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview